In addition to PARP, PARG inhibition has also been explored for cancer treatment, following the resolution of the structure of the PARG catalytic site (Slade et al, 2011; Dunstan et al, 2012; Kim et al, 2012; Barkauskaite et al, 2013). Here, PARG is linked to cancer.